Lupin gets tentative nod for three HIV drugs
Lupin, headquartered in Mumbai, India, has received tentative approval from the FDA under the US President’s Emergency Plan for AIDS Relief for its
Lupin, headquartered in Mumbai, India, has received tentative approval from the FDA under the US President’s Emergency Plan for AIDS Relief for its
Pfizer refuted allegations by Project Veritas, a media organization, in its ongoing COVID-19 vaccine work stating it has “not conducted gain-of-function” or “directed
Studies on animals have shown that a drug used to treat hypertension prolongs the human lifespan and slows ageing, mimicking the effects of
COVID-19 will remain a pandemic as it continues to constitute a public health emergency of international concern, the WHO’s highest form of an
The number of people affected by neglected tropical diseases (NTDs) has fallen by 80 million between 2020 and 2021, a WHO report stated.
PathLabs Unifiers, a subsidiary of diagnostic services company Dr. Lal PathLabs, has acquired a 10% stake in one of its business units, APRL
Sun Pharmaceuticals announced it had acquired three brands from Aksigen to treat postoperative inflammation in patients undergoing minor surgery and dental procedures.
Dr. Reddy's unveiled its difluprednate ophthalmic emulsion in the US market for treating inflammation and pain associated with eye surgery.
The receptor of Oxytocin, a hormone considered essential to forming social bonds, may not play the role that scientists have assigned it for
Eli Lilly announced that it had received US FDA approval for a tablet to treat a rare form of blood cancer.